Basit öğe kaydını göster

dc.contributor.authorPeterson, Francis C.
dc.contributor.authorElgin, Emine Sonay
dc.contributor.authorNelson, Timothy J.
dc.contributor.authorZhang, Fuming
dc.contributor.authorHoeger, Theresa J.
dc.contributor.authorLinhardt, Robert J.
dc.contributor.authorVolkman, Brian F.
dc.date.accessioned2020-11-20T16:45:18Z
dc.date.available2020-11-20T16:45:18Z
dc.date.issued2004
dc.identifier.issn0021-9258
dc.identifier.issn1083-351X
dc.identifier.urihttps://doi.org/10.1074/jbc.M311633200
dc.identifier.urihttps://hdl.handle.net/20.500.12809/5360
dc.descriptionWOS: 000220334900073en_US
dc.descriptionPubMed ID: 14707146en_US
dc.description.abstractChemokine-mediated recruitment of leukocytes in vivo depends on interactions with cell surface glycosaminoglycans. Lymphotactin, the unique member of the "C" chemokine subclass, is a highly basic protein that binds heparin, a glycosaminoglycan, with high affinity ( similar to 10 nM). We detected lymphotactin-heparin binding by NMR and mapped this interaction to a narrow surface that wraps around the protein. Substitutions in and around this binding site and surface plasmon resonance analysis of heparin binding affinity identified two arginine residues of lymphotactin as critical for glycosaminoglycan binding. Both arginine mutant proteins and the combined double mutant had dramatically diminished in vivo activity in a leukocyte recruitment assay, suggesting that the lymphotactin-glycosaminoglycan interactions detected in vitro are important for the function of this chemokine. Our results demonstrate that like other chemokines, lymphotactin utilizes highly specific glycosaminoglycan-binding sites that represent potential targets for drug development.en_US
dc.description.sponsorshipNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI045843, R01AI045843, R01AI045843, R01AI045843] Funding Source: NIH RePORTER; NIAID NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01 AI045843-04, R01 AI045843, R01 AI045843-03] Funding Source: Medlineen_US
dc.item-language.isoengen_US
dc.publisherAmer Soc Biochemistry Molecular Biology Incen_US
dc.item-rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectGlycosaminoglycanen_US
dc.titleIdentification and characterization of a glycosaminoglycan recognition element of the C chemokine lymphotactinen_US
dc.item-typearticleen_US
dc.contributor.departmentMÜ, Fen Fakültesi, Kimya Bölümüen_US
dc.contributor.institutionauthorElgin, Emine Sonay
dc.identifier.doi10.1074/jbc.M311633200
dc.identifier.volume279en_US
dc.identifier.issue13en_US
dc.identifier.startpage12598en_US
dc.identifier.endpage12604en_US
dc.relation.journalJournal of Biological Chemistryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster